CNO

CNO Financial is a middle-market life, health and annuity insurer whose FY2025 headline looks worse than the business performed. Net income fell 45.5% to $229M and EPS dropped 40.9% to $2.30, yet operating income was essentially flat (+0.4% to $553M) and revenue edged up 0.9% to $4.49B. That divergence is characteristic of insurance GAAP — the swing is driven by below-operating items such as investment mark-to-market and actuarial assumption effects, not by deterioration in the underlying insurance franchise. Operating cash flow actually grew 7.6% to $676M.

Management is returning capital aggressively and accretively: $331M of buybacks (up 10.4%) cut the share count 6.5%, with another $66.2M in dividends, while equity still grew 4.9% to $2.64B and retained earnings rose 7.2%. On stable operating earnings, the 22.1x trailing P/E overstates the multiple — the operating-earnings yardstick implies a more reasonable valuation, and at 1.1x sales the stock is not demanding. The 8.7% ROE is modest but the steady buyback meaningfully boosts per-share metrics over time.